🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2024-516472-15-00
Authorised Phase I

A phase 1 glucose clamp trial investigating the bioequivalence of CVC-001 cartridge vs U.S.-Licensed Lantus® in healthy male volunteers

2024-516472-15-00 · tracked via the Priya Life Science EU tracker
Sponsor
Civica Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Nutritional and Metabolic Diseases
Decision date
12/12/2025
Enrollment target
76
Sites
Germany

Condition studied

Type 1 diabetes mellitus (healthy participants)

Eligibility

Age group
18-64 years
Sex
Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2024-516472-15-00 on CTIS ↗ ← All trials in the EU